ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.35%
S&P ASX All Technology
3,067.50
0.14%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.50761
0.00%
Bitcoin
61,149.92
0.58%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Transkaryotic Therapies (MM) (TKTX)

  7. Transkaryotic Therapies (MM) (TKTX) News

TKTX

Transkaryotic Therapies (TKTX)

Transkaryotic Therapies (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TKTX
DateTimeSourceHeadlineSymbolCompany
27/02/202008:05GlobeNewswire Inc.CRISPR Therapeutics Proposes Changes to the Board of DirectorsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/07/200501:36PR Newswire (US)TKT Stockholders Approve Acquisition by ShireNASDAQ:TKTXTranskaryotic Therapies (MM)
15/07/200508:22PR Newswire (US)TKT Confirms That Board of Directors Unanimously Recommends That Stockholders Approve Shire TransactionNASDAQ:TKTXTranskaryotic Therapies (MM)
12/07/200523:01PR Newswire (US)TKT Issues Open Letter to StockholdersNASDAQ:TKTXTranskaryotic Therapies (MM)
28/06/200504:14PR Newswire (US)TKT to Hold Special Meeting of Stockholders on July 27, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
20/06/200523:01PR Newswire (US)TKT Reports Positive Top-Line Results of Hunter Syndrome Pivotal TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
13/06/200523:41PR Newswire (US)TKT Announces Expiration of Both Hart-Scott-Rodino Waiting Period and SEC Review Period of Preliminary Proxy StatementNASDAQ:TKTXTranskaryotic Therapies (MM)
05/05/200523:00PR Newswire (US)TKT Announces First Quarter 2005 ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
28/04/200509:23PR Newswire (US)TKT Assessing Impact of Fire at Manufacturing FacilityNASDAQ:TKTXTranskaryotic Therapies (MM)
28/04/200507:30PR Newswire (US)TKT to Report First Quarter 2005 Financial Results on May 5, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
22/04/200500:50PR Newswire (US)TKT Announces Agreement to be Acquired by Shire for $1.6 BillionNASDAQ:TKTXTranskaryotic Therapies (MM)
21/04/200500:43PR Newswire (US)TKT Achieves GA-GCB Clinical MilestoneNASDAQ:TKTXTranskaryotic Therapies (MM)
30/03/200506:23PR Newswire (US)TKT Announces Appointment of Eric Pauwels as Senior Vice President, Global Commercial OperationsNASDAQ:TKTXTranskaryotic Therapies (MM)
29/03/200508:04PR Newswire (US)New Website Offers Comprehensive Information on Hunter SyndromeNASDAQ:TKTXTranskaryotic Therapies (MM)
25/03/200501:30PR Newswire (US)TKT to Present at Two Upcoming Healthcare ConferencesNASDAQ:TKTXTranskaryotic Therapies (MM)
18/03/200500:01PR Newswire (US)Notice to All Deutsche Bank Securities Inc. Clients From the Securities Arbitration Law Firm of Klayman & Toskes, P.A.NASDAQ:TKTXTranskaryotic Therapies (MM)
10/03/200506:21PR Newswire (US)TKT to Present at SG Cowen Securities' 25th Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
24/02/200500:00PR Newswire (US)Strong Year of Execution Produces Solid 2004 Financial PerformanceNASDAQ:TKTXTranskaryotic Therapies (MM)
16/02/200501:31PR Newswire (US)Tamara L. Joseph Named General Counsel of TKTNASDAQ:TKTXTranskaryotic Therapies (MM)
11/02/200501:17PR Newswire (US)TKT to Report Fourth Quarter and Year-End 2004 Financial Results on February 23, 2005NASDAQ:TKTXTranskaryotic Therapies (MM)
05/02/200501:15PR Newswire (US)TKT Appoints Theresa Heggie as General Manager, EuropeNASDAQ:TKTXTranskaryotic Therapies (MM)
25/01/200507:59PR Newswire (US)Genzyme Sues to Halt TKT Gaucher TrialNASDAQ:TKTXTranskaryotic Therapies (MM)
12/01/200508:01PR Newswire (US)TKT Provides Update on Product Pipeline at JPMorgan Healthcare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
05/01/200502:02PR Newswire (US)TKT to Present at JPMorgan's Annual HealthCare ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
10/12/200403:23PR Newswire (US)TKT to Present at Wachovia Biotechnology ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
13/11/200401:15PR Newswire (US)TKT Announces Executive PromotionsNASDAQ:TKTXTranskaryotic Therapies (MM)
10/11/200400:35PR Newswire (US)TKT to Present At SG Cowen's Fifth Annual Global Health Care ConferenceNASDAQ:TKTXTranskaryotic Therapies (MM)
10/11/200400:30PR Newswire (US)TKT Reports Third Quarter 2004 Financial ResultsNASDAQ:TKTXTranskaryotic Therapies (MM)
30/10/200406:58PR Newswire (US)TKT To Report Third Quarter Financial Results On November 9, 2004NASDAQ:TKTXTranskaryotic Therapies (MM)
29/10/200408:01PR Newswire (US)TKT's Research Findings on Intrathecal Delivery of I2S Presented at ASHGNASDAQ:TKTXTranskaryotic Therapies (MM)
 Showing the most relevant articles for your search:NASDAQ:TKTX

Your Recent History

ASX
WES
Wesfarmers
CCOM
SILVER
SILVER
ASX
XAO
Australian SE All Ordina...
ASX
RIO
Rio Tinto
NYSE
MRK
Merck
ASX
AMP
AMP
ASX
SUN
Suncorp
NASDAQ
TSLA
Tesla
FX
GBPAUD
Sterling vs AUD
ASX
NCM
Newcrest Mining
NYSE
DIS
Walt Disney
COIN
BTCUSD
Bitcoin
NYSE
VZ
Verizon Communications
NASDAQ
AAPL
Apple
NASDAQ
GOOGL
Alphabet
SPI
SP500
S&P 500
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved